Differences in Physicians Understanding of Biologics and Biosimilars in the U.S. and Europe

Share on facebook
Share on twitter
Share on linkedin
GAfPA and Alliance for Safe Biologics poster presentation, 20th International Congress of Parkinson’s Disease and Movement Disorders; MDS Congress 2016